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Abstract
Background: The use of radiofrequency ablation (RFA) for cancer is increasing; however, post-discharge
outcomes have not been well described. The aim of the present study was to determine rates of
hospital-based, acute care utilization within 30 days of discharge after RFA.
Methods: Using state-level data from California, patients were identified who were at least 40 years of
age who underwent RFA of hepatic tumours without a concurrent liver resection from 2007–2011. Our
primary outcome was hospital readmissions or emergency department visits within 30 days of discharge.
A multivariable regression model was constructed to identify patient factors associated with these events.
Results: The final sample included 1764 patients treated at 100 centres. Hospital readmissions (11.3/
100 discharges), emergency department visits (6.0/100 discharges) and overall acute care utilization
(17.3/100 discharges) were common. Most encounters occurred within 10 days of discharge for diag-
noses related to the procedure. Patients with renal failure [adjusted odds ratio (AOR) = 1.98 (1.11–3.53)],
obesity [AOR = 1.69 (1.03–2.77)], drug abuse [AOR = 2.95 (1.40–6.21)] or those experiencing a compli-
cation [AOR = 1.52 (1.07–2.15)] were more likely to have a hospital-based acute care encounter within
30 days of discharge.
Conclusions: Hospital-based acute care after RFA is common. Patients should be counselled regarding
the potential for acute care utilization and interventions targeted to high-risk populations.
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Introduction
Radiofrequency ablation (RFA) of primary or metastatic hepatic
tumours is indicated as an adjunct to a formal hepatic resection
or as primary treatment in selected patients. Because it is often
considered less morbid and better tolerated than a formal liver
resection, it has allowed patients who previously went untreated
to receive care. Over the last decade, the use of RFA for the treat-
ment of hepatic tumours has markedly increased, particularly
among patients who are not surgical candidates for major liver
resections.1,2
As this procedure has become more widely adopted in the
community setting, in-hospital morbidity and mortality have
been higher than initially reported.3 Early reports of this technol-
ogy from single institutions with formal liver treatment centres
showed low morbidity and mortality rates of 8.9% and 0.5%,
respectively.4 Recent data suggests that with broader adoption of
the procedure into less-experienced centres, in-hospital morbidity
may be as high as 18%.3 However, complications occurring during
the hospital encounter, which is often brief, may only represent
a fraction of the procedure-related morbidity. For example,
patients may develop a hepatic abscess, post-operative infection or
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pneumonia up to 30 days after discharge5 with many of these
events requiring additional contact with the healthcare system,
particularly hospital readmissions and emergency department
visits.
While prior studies3,5,6 have evaluated in-hospital outcomes in
the community setting, few studies have evaluated the need for
hospital readmission or emergency department visits after dis-
charge among patients who undergo RFA of hepatic tumours.
Defining these post-discharge events would improve our under-
standing of procedure-related morbidity, healthcare needs after
treatment and identify patients who are more likely to require
additional hospital encounters. Therefore, we conducted this
study using a multi-payer, population-based database to deter-
mine hospital readmission and emergency department visit rates
within 30 days of RFA of hepatic tumours and to identify patient
level factors associated with these encounters after discharge.
Methods
We conducted a retrospective cohort study using data from the
2007–2011 California ambulatory surgery,7 inpatient8 and emer-
gency department databases.9 These data are a census of dis-
charges from free-standing and hospital-affiliated ambulatory
surgery centres; acute care, non-federal, community hospitals;
and all emergency department visits which did not result in hos-
pital admission, respectively. Each patient discharge includes up to
21 Current Procedural Terminology (CPT) or International Classi-
fication of Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) procedure codes, 15 diagnostic ICD-9-CM codes, and
information about patient demographics, anticipated payer, and
discharge disposition. Additionally, all three datasets contain
encrypted patient identifiers which allow patients to be followed
over time and across datasets.
Patient selection
From the ambulatory surgery and inpatient databases, we identi-
fied all patients of at least 40 years of age who underwent an
elective RFA (ICD-9-CM 50.23–50.26 or CPT 47382, 47370, or
47380) for hepatocellular carcinoma or other primary or meta-
static malignancies (ICD-9-CM 155, 155.0–155.5, 156, 156.0–
156.9, 197.7) between January 2007 and September 2011. This age
threshold was selected because few patients in our sample (N = 35)
were younger than 40 years of age; the incidence of disease not
amenable to a formal hepatic resection in this age group is low;
and it provided consistency with prior study.3 In order to focus on
the outcomes of RFA independently, we excluded patients who
underwent a concurrent surgical procedure other than a cholecys-
tectomy. Additionally, we sequentially excluded patients with a
discharge disposition listed as missing (N = 4), left against medical
advice (N = 1) or death (N = 10). These steps were taken to ensure
all patients had a routine discharge and survived to be ‘at risk’ for
the outcomes. If a patient had more than one discharge meeting
these criteria (N = 194), we selected the first discharge for study.
Defining the outcome variables
Our primary outcome for this study was hospital-based acute care
within 30 days of discharge.10 This was defined as either a hospital
readmission or an emergency department visit not resulting in
hospital admission. Hospital readmissions were identified from
the inpatient database, whereas emergency department visits not
resulting in admission were identified from the emergency depart-
ment database. Because our objective was to identify hospital-
based, acute care that was not part of a pre-planned course of care,
we excluded hospital readmissions not originating from the emer-
gency department where the primary diagnosis was maintenance
radiation or chemotherapy, rehabilitation services, or cancer. All
hospital admissions that were admitted from the emergency were
included, regardless of the primary diagnosis. For all identified
hospital-based, acute care encounters within 30 days of discharge,
we recorded the primary diagnosis associated with the encounter
based on the first listed diagnostic ICD-9-CM code. As a result of
limitations in the data, costs related to these return visits was
unable to be evaluated.
Independent variables
Several patient and procedure characteristics were recorded at the
time of treatment for both descriptive purposes and subsequent
regression modelling. These factors included patient age group in
years (40–59, 60–69 and 70 plus), gender, race and ethnicity
(White, Black, Hispanic, Other and Missing) and anticipated
primary payer status (Medicare, Medicaid, Private and Self-pay).
As a measure of patient health, we assessed medical comorbidity
according to the enhanced-Elixhauser algorithm described by
Quan11,12 which identifies 31 chronic medical conditions. Condi-
tions which were present in the entire population (cancer) or less
than 1.0% of the population were excluded (pulmonary circula-
tory disorders, paralysis, peptic ulcer disease, AIDS/HIV, blood
loss or deficiency anaemia and psychoses). Additionally, we iden-
tified several surgery specific variables including the approach
taken (open, percutaneous, laparoscopic or not specified),
whether the procedure was conducted in the inpatient or outpa-
tient setting, and if a concurrent cholecystectomy was performed.
Finally, we identified whether RFA-specific complications of care
(need for transfusion of blood products, injury to surrounding
organs intra-operatively, hepatic failure, pneumothorax, abscess,
need for endoscopic intervention) occurred. This was based on
secondary diagnostic ICD-9-CM coding from the initial encoun-
ter consistent with prior descriptions.3
Statistical analysis
Characteristics of the overall sample were presented with descrip-
tive statistics. The observed hospital readmission, emergency
department visit and overall hospital-based, acute care rate within
30 days was calculated. This was done by dividing the total
number of hospital-based, acute care events (numerator) by the
total number of patients in the population (denominator). This
rate was then expressed as the number of events per 100 dis-
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charges. In this way, a single patient could contribute multiple
events to the rate. Finally, we constructed a multivariable logistic
regression model to identify patient level variables associated with
more frequent hospital-based acute care. In this model, hospital-
based acute care was the dependent variable and all previously
described covariates were potential independent variables (age
group, gender, anticipated primary payer, 18 chronic medical con-
ditions, surgical approach, concurrent cholecystectomy, whether
the procedure was outpatient or inpatient and if any complica-
tions of care occurred). Prior to entering these variables in the
model, a Spearman’s correlation matrix was used to assess for
collinearity between variables with none being identified. The
most parsimonious model was then determined through a back-
ward selection process using variable entry and retainment
thresholds of 0.99 and 0.05, respectively. Results of the final model
are presented as odds ratios (ORs) with 95% confidence intervals
(CIs).
All analyses were conducted using SAS version 9.3 (SAS Insti-
tute, Cary, NC, USA). Because this study used publicly available
data that does not include patient identifiers, it was considered
exempt from review by the Wright State University Institutional
Review Board.
Results
The final example included 1764 patients. Most patients were
white (50.3%), male (62.0%), over 60 years of age (63.9%) and
had either Medicare (46.4%) or Private (39.5%) insurance.
Primary hepatic malignancy (54.5%) was slightly more common
than metastatic disease (43.1%) during the encounter in which
RFA was performed. When metastatic disease was the primary
diagnosis, colorectal cancer (45.6%) was themost frequently iden-
tifiable cancer history.However, a prior site-specific cancer history
was unavailable in 30.9%. Radiofrequency ablation was most
commonly approached by a laparoscopy (45.7%) followed by per-
cutaneous techniques (25.9%) and open surgery (22.2%).Overall,
616 (34.9%) had an outpatient procedure and 176 (10.0%) had a
concurrent cholecystectomy (Table 1). During the initial hospital
encounter when RFAwas performed, 266 patients (15.1%) experi-
enced at least one procedure-specific complication. Most com-
monly, these included the need for a blood transfusion (8.6%),
intra-operative bleeding or injury to surrounding structures
(3.0%) and hepatic failure (3.0%).
Hospital-based, acute care within 30 days
of discharge
Among the overall population (N = 1764), 242 patients (13.7%)
experienced 305 hospital-based, acute care encounters within 30
days of discharge. Of those who returned to the hospital, 19.0% of
these patients experienced more than one encounter. In total, the
overall rate of hospital-based, acute care encounters within 30
days of RFA was 17.3 events per 100 discharges with hospital
admission (11.3/100 discharges) occurring more frequently than
did emergency department visits (6.0/100 discharges). When we
included all hospital readmissions in our analysis rather than the
exclusion criteria previously described, our estimates of hospital-
based, acute care utilization did not change.
Most events (51.1%) occurred within the first 10 days of dis-
charge with a decline in hospital admissions or emergency depart-
ment visits after the first week (Fig. 1).When stratified by whether
RFA was performed in an inpatient or ambulatory surgery setting,
the overall rate of hospital-based, acute care was 18.9 events per
100 discharges among inpatients and 14.1 events per 100 dis-
charges among ambulatory patients (Table 2). The most common
diagnoses associated with hospital returns was abdominal or chest
pain and pyrexia. Other common reasons for hospital return
included exacerbation of underlying liver disease and complica-
tions of treatment, including post-operative infections (Table 3).
Patient factors associated with hospital-based acute
care within 30 days
The final regression model included several factors associated
with more frequent hospital-based, acute care encounters in the
30 days after discharge. Patients with a history of renal failure
[adjusted odds ratio (AOR) = 1.98 (1.11–3.53)], obesity [AOR =
1.69 (1.03–2.77)], drug abuse [AOR = 2.95 (1.40–6.21)] or those
experiencing a complication during the procedure [AOR = 1.52
(1.07–2.15)] were more likely to have a hospital-based acute care
encounter within 30 days of discharge. Conversely, patient age of
at least 70 years appeared to be associated with fewer hospital-
based, acute care encounters compared with patients aged 40–59
years. This should be interpreted with caution and likely repre-
sents patient selection in the older age groups. Similarly, patients
with private forms of health insurance were less likely to return to
the hospital within 30 days [AOR = 0.62 (0.43–0.91)] and may
reflect a younger, healthier population (Table 4).
Although surgical approach was not retained in the final model,
we evaluated the relationship between hospital-based, acute
care utilization and the surgical approach employed (open,
laparoscopic, percutaneous or not specified). Immediate RFA-
specific morbidity [open (O) = 25.3%, laparoscopic (L) = 9.4%,
percutaneous (P) = 14.7%, not specified (N) = 21.8%, P < 0.001]
and post-operative morbidity [O = 21.5%, L = 2.2%, P = 12.3%,
N = 15.5%, P < 0.001] was experienced differently across groups
and may reflect the complexity of the case or patient disease
process. However, after discharge, the frequency of hospital-based
acute care was similar across groups (O = 14.6%, L = 13.9%, P =
11.8%, N = 17.3%, P < 0.42).
Additionally, as a result the limitations of the administrative
data, we cannot adequately address how the degree of tumour
burden or extent of tissue ablation is related to the post-discharge
outcomes. In our sample, most patients had primary hepatic
tumours followed rather than metastatic disease.When we stratify
outcomes based on these diagnoses, no difference is noted in
RFA-specific, post-operative, or hospital-based acute care within
30 days (data not shown).
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Discussion
Hospital-based, acute care utilization after RFA for hepatic
tumours is common. In addition to the 15.1% procedure-specific
complication rate noted during the index encounter, a similar
number of patients (13.7%) experienced at least one hospital
readmission or emergency department visit within 30 days of
discharge. Many of these encounters were for symptoms of pain,
fever or post-procedure complications, including infections,
within the first 10 days of discharge. At the time of discharge,
patients with certain comorbid medical conditions and those
experiencing a complication of the procedure were more likely to
return to the hospital. The timing, diagnoses and relationship to
procedural complications suggest that these post-discharge events
should be closely monitored and patients counselled regarding the
potential need for additional care.
While RFAof hepatic tumours has broadened treatment options
for patients and is associated with lower morbidity than formal
Table 1 Description of 1764 patients who underwent radiofrequency ablation of hepatic tumours in California between January 2007 and
September 2011 according to the setting of treatment
Overall population Inpatient population Outpatient population
N % i % N %
Overall 1764 100.0 1148 65.1 616 34.9
Age group in years
40–59 636 35.1 420 36.6 216 35.1
60–69 574 32.5 382 33.3 192 31.2
70 plus 554 31.4 346 30.1 208 33.8
Gender
Male 1093 62.0 729 63.5 364 59.1
Female 614 34.8 408 35.5 206 33.4
Race and ethnicity
White 887 50.3 589 51.3 298 48.4
Black 79 4.5 54 4.7 25 4.1
Hispanic 249 14.1 179 15.6 70 11.4
Other 426 24.1 289 25.2 137 22.2
Missing 123 7.0 37 3.2 86 14.0
Primary payer
Medicare 819 46.4 514 44.8 305 49.5
Medicaid 194 11.0 133 11.6 61 9.9
Private 696 39.5 472 41.1 224 36.4
Self-pay 55 3.1 29 2.5 26 4.2
Elixhauser conditionsa
None 422 23.9 168 14.6 254 41.2
1–2 conditions 798 45.2 515 44.9 283 45.9
3 + conditions 544 30.8 465 40.5 79 12.8
Concurrent
cholecystectomy
176 10.0 174 15.2 * *
Surgical approach
Open 391 22.2 388 33.8 * *
Laparoscopic 807 45.7 325 28.3 482 78.2
Percutaneous 456 25.9 328 28.6 128 20.8
Not specified 110 6.2 107 9.3 * *
Complications of careb 266 15.1 256 22.3 * *
aSome conditions were excluded owing to confidentiality concerns because they were present in less than 1% of the population being studied or
because they applied to the entire population (i.e. a cancer diagnosis).
bIncludes the need for transfusion of blood products, injury to surrounding organs intra-operatively, hepatic failure, pneumothorax, abscess, need for
endoscopic intervention, or other complications of post-operative care based on ICD-9-CM coding.
*Cells with small sample sizes are masked to conform to data use agreements and protect patient privacy.
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resection, it is not without its own potential complications during
the initial encounter and after discharge.Current studies from insti-
tutions with technical expertise in this procedure have reported
procedure-related morbidity during the initial encounter to be less
than 10%.5,6 However,when in-hospital, procedure-relatedmorbid-
ity is evaluated in a national sample, the rate is substantially higher at
18%.3 Because the hospitalization is often brief for this procedure,
patients may be discharged prior to the development of complica-
tions.13 In the present study, we found 13.7% of patients required at
least one hospital-based, acute care encounter within 30 days. Most
commonly, these encounters were for complications of the pro-
cedure or an acute worsening of the patient’s underlying disease.
As healthcare payers, including the Centers for Medicare and
Medicaid Services, scrutinize post-discharge outcomes, it will
become increasingly important to identify patient factors which
may identify groups at ‘high risk’ for return. In this population,
several comorbid medical conditions were associated with more
frequent hospital-based acute care including obesity, renal failure
and drug abuse. Of them, obesity has been a well-described con-
dition associated with adverse surgical events.14,15 Further, drug
abuse specifically, and mental health conditions in general, have
also been related to adverse events in the surgical oncology popu-
lation.16 Patients who experienced a complication of care were also
more likely to experience a hospital-based acute care encounter. A
growing body of evidence has shown a relationship between the
quality of care during the initial encounter and post-discharge
outcomes.17,18 Efforts to improve inpatient quality may also
improve post-discharge outcomes.
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Figure 1 Acute care utilization after radiofrequency ablation (RFA). The X-axis represents the number of days since ambulatory surgery
centre discharge. The Y-axis (bar chart) represents the total number of events per day. The Y-axis (line graph) represents daily events per
100 discharges
Table 2 Rate of hospital-based, acute care within 30 days of radiofrequency ablation for cancer per 100 discharges
N Hospital
admissions
Emergency
department visitsa
Hospital based
acute care
Overall 1764 11.3 6.0 17.3
Inpatient 1168 12.1 6.8 18.9
Outpatient 596 9.7 4.4 14.1
aThis included emergency department visits that did not result in subsequent hospital admission. Emergency department visits resulting in hospital
admission were counted under ‘hospital admissions.’
Table 3 Diagnoses associated with hospital-based, acute care within 30 days of radiofrequency ablation of hepatic tumours based on the
first listed diagnostic ICD-9-CM coding
Most common 2nd 3rd 4th 5th
Overall Abdominal pain Pyrexia Chest pain Post-operative infections Urinary infections
Inpatient Post-operative infections Abdominal pain Hepatic coma Cirrhosis Acute renal failure
Outpatient Chest pain Abdominal pain Pyrexia Cervicalgia Urinary infections
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The present study should be interpreted in the context of
several limitations. First, specific tumour characteristics including
number, size and location cannot be determined from the current
dataset. As such, the influence of these variables on outcomes
cannot be determined. Second, patients who returned to a hospi-
tal outside of California could not be accounted for in this study.
To limit the influence of this factor, we restricted our population
to California residents. Third, the dataset utilized is subject to the
accuracy of the coding provided. Identifying specific complica-
tions from administrative data can be problematic. 19 Finally, costs
of care were not available for a substantial number of patients
preventing our ability to study the financial impact of these events
to the patient or healthcare system.
In conclusion, patients who undergo RFA of hepatic tumours
may experience adverse events leading to hospital-based, acute
care encounters after discharge. Our present data suggests certain
patient conditions and the quality of care provided during the
initial hospitalization may be directly related to post-discharge
outcomes. Further research is needed to understand the reasons
patients return to the hospital for care, particularly those not
requiring a hospital admission, so that interventions can be
designed to reduce these events.
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